Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Ganesh Pawar Article rating: 3.2

The market opened in red on February 04, 2021, overall volumes in futures & options currently stand at 4,43,52,960 contracts with a turnover of Rs. 42,11,837.60 crore.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Ganesh Pawar Article rating: 3.9

The market opened in red on February 04, 2021, overall volumes in futures & options currently stand at 4,43,52,960 contracts with a turnover of Rs. 42,11,837.60 crore.

Reliance Industries divests from Reliance Marcellus LLC; share trades flat
Reliance Industries divests from Reliance Marcellus LLC; share trades flat

Reliance Industries divests from Reliance Marcellus LLC; share trades flat

Abhinav Lahoti Article rating: 3.8

Reliance Marcellus, LLC (RMLLC), a wholly-owned subsidiary of Reliance Industries Limited (RIL) announced the signing of agreements on Thursday to divest all its interest in certain upstream assets in Marcellus shale play of south-western Pennsylvania.  

HCL Technologies signs multi-year contract with Airbus
HCL Technologies signs multi-year contract with Airbus

HCL Technologies signs multi-year contract with Airbus

Chinmayee D Article rating: 4.5

A leading global technology company, HCL Technologies Ltd announced on Thursday that the company has inked a five-year agreement with Airbus for digital workplace services.

Dilip Buildcon becomes best bidder for railway works in Chhattisgarh
Dilip Buildcon becomes best bidder for railway works in Chhattisgarh

Dilip Buildcon becomes best bidder for railway works in Chhattisgarh

Abhinav Lahoti Article rating: 5.0

Dilip Buildcon Limited has been declared as L-1 bidder on percentage rate (EPC Project) for civil works, which include earthwork required for the formation of railways in the state of Chhattisgarh over South East Central Railway, Package II. 

Zydus Cadila completes phase I trials of ZY19489A, single-dose cure for Malaria
Zydus Cadila completes phase I trials of ZY19489A, single-dose cure for Malaria

Zydus Cadila completes phase I trials of ZY19489A, single-dose cure for Malaria

Apurva Joshi Article rating: 4.7

Zydus Cadila has announced that its antimalarial compound ZY19489 (MMV253) in collaboration with a Swiss-based product development partnership Medicines for Malaria Venture (MMV) has now completed Phase I clinical evaluation [registration number-ACTRN12619000127101].

Stocks that are likely to record significant movement on bourses today
Stocks that are likely to record significant movement on bourses today

Stocks that are likely to record significant movement on bourses today

Karan Dsij Article rating: 4.3

UltraTech Cement: The Finance Committee approved raising funds by way of issuance of foreign currency (US$) denominated bonds (Notes) aggregating up to US$ 400 million, corresponding to Rs 3,000 crore, to be offered and sold within the United States to the qualified institutional buyer (QIB).

Volatility vibes on weekly expiry!
Volatility vibes on weekly expiry!

Volatility vibes on weekly expiry!

Karan Dsij Article rating: 4.6

With weekly expiry on the cards and the put-call ratio (PCR) being at the higher side at 1.61, we could witness bouts of volatility. However, as long as Nifty trades above its previous all-time high of 14,754, it is a buy-on-dips market. While on the upside, the target is placed around 14,932 as the upper Bollinger band is present at these levels. 

RSS
First19691970197119721974197619771978Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR